{"id":77257,"date":"2026-11-20T03:37:23","date_gmt":"2026-11-20T03:37:23","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77257"},"modified":"2026-11-20T03:44:54","modified_gmt":"2026-11-20T03:44:54","slug":"american-analyst-ratings-updates-november-19-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/","title":{"rendered":"American Analyst Ratings Updates: November 19, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=77257&amp;preview=true\">Analyst Ratings (USA)<\/a><\/h2>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<p>The Amercan market outlook remains mixed, with analysts showing optimism toward technology, healthcare and industrial stocks, while consumer discretionary and financial services face greater caution. Selective upgrades and higher price targets suggest confidence in earnings growth, although valuation pressures and economic uncertainty remain concerns. Overall, analysts favour companies with strong fundamentals, sustainable profitability and attractive growth prospects amid continued market volatility.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h3><strong>Updates (282)<\/strong><\/h3>\n<p><strong>Ameris Bancorp (ABCB)<\/strong> \u2014 Keefe Bruyette &amp; Woods maintained its Outperform rating with a price target of $95.00.<\/p>\n<p><strong>Abbott Laboratories (ABT)<\/strong> \u2014 Leerink Partners upgraded the stock from Market Perform to Outperform, with a price target of $124.00.<\/p>\n<p><strong>AECOM (ACM)<\/strong> \u2014 Truist updated its price target from $75.00 to $97.00, maintaining a Buy rating.<\/p>\n<p><strong>AECOM (ACM)<\/strong> \u2014 RBC Capital Markets raised its price target from $89.00 to $102.00, maintaining an Outperform rating.<\/p>\n<p><strong>Accenture (ACN)<\/strong> \u2014 Bank of America resumed coverage with a Buy rating and a price target of $288.00.<\/p>\n<p><strong>Accenture (ACN)<\/strong> \u2014 Guggenheim maintained its Buy rating.<\/p>\n<p><strong>Analog Devices (ADI)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n<p><strong>Automatic Data Processing (ADP)<\/strong> \u2014 Bank of America resumed coverage with a Buy rating and a price target of $345.00.<\/p>\n<p><strong>ADARx Pharmaceuticals (ADRX)<\/strong> \u2014 JPMorgan lowered its price target from $38.00 to $36.00, maintaining an Overweight rating.<\/p>\n<p><strong>ADTRAN (ADTN)<\/strong> \u2014 Argus downgraded the stock from Hold to Sell.<\/p>\n<p><strong>Atlas Energy Solutions (AESI)<\/strong> \u2014 Raymond James set a price target of $12.00, with an Outperform rating.<\/p>\n<p><strong>Agilon Health (AGL)<\/strong> \u2014 Bernstein raised its price target from $125.00 to $138.00, maintaining an Outperform rating.<\/p>\n<p><strong>Arthur J. Gallagher &amp; Co. (AJG)<\/strong> \u2014 Wells Fargo downgraded the stock from Overweight to Equal Weight and adjusted its price target from $312.00 to $294.00.<\/p>\n<p><strong>Amgen (AMGN)<\/strong> \u2014 Piper Sandler updated its price target from $457.00 to $542.00, maintaining an Overweight rating.<\/p>\n<p><strong>Amylyx Pharmaceuticals (AMLX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $55.00.<\/p>\n<p><strong>Amrize (AMRZ)<\/strong> \u2014 JPMorgan lowered its price target from $48.00 to $46.00, maintaining a Neutral rating.<\/p>\n<p><strong>Arista Networks (ANET)<\/strong> \u2014 Morgan Stanley set a price target of $250.00.<\/p>\n<p><strong>Aon (AON)<\/strong> \u2014 Wells Fargo downgraded the stock from Overweight to Equal Weight, with a price target of $364.00.<\/p>\n<p><strong>Anthropic (ANT)<\/strong> \u2014 Citizens initiated coverage with a Market Outperform rating and a price target of $125.00.<\/p>\n<p><strong>Anthropic (ANT)<\/strong> \u2014 Melius initiated coverage with a Buy rating and a price target of $155.00.<\/p>\n<p><strong>Anthropic (ANT)<\/strong> \u2014 Needham initiated coverage with a Buy rating and a price target of $150.00.<\/p>\n<p><strong>Anthropic (ANT)<\/strong> \u2014 Wolfe Research initiated coverage with a Outperform rating and a price target of $135.00.<\/p>\n<p><strong>AppLovin (APP)<\/strong> \u2014 StoneX raised its price target from $440.00 to $469.00, maintaining a Buy rating.<\/p>\n<p><strong>Aramark (ARMK)<\/strong> \u2014 Citigroup lowered its price target from $75.50 to $72.50, maintaining a Buy rating.<\/p>\n<p><strong>AST SpaceMobile (ASTS)<\/strong> \u2014 B. Riley Financial upgraded the stock from Neutral to Buy, with a price target of $48.00.<\/p>\n<p><strong>AxoGen (AXGN)<\/strong> \u2014 Leerink Partners raised its price target from $56.00 to $65.00, maintaining an Outperform rating.<\/p>\n<p><strong>Alibaba Group (BABA)<\/strong> \u2014 Susquehanna maintained its Positive rating.<\/p>\n<p><strong>Alibaba Group (BABA)<\/strong> \u2014 Barclays set a price target of $155.00, with an Overweight rating.<\/p>\n<p><strong>Alibaba Group (BABA)<\/strong> \u2014 Jefferies Financial Group set a price target of $161.00, with a Buy rating.<\/p>\n<p><strong>Braskem (BAK)<\/strong> \u2014 UBS lowered its price target from $1.50 to $0.75, maintaining a Sell rating.<\/p>\n<p><strong>Bath &amp; Body Works (BBWI)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating with a price target of $21.00.<\/p>\n<p><strong>Bloom Energy (BE)<\/strong> \u2014 BMO Capital Markets upgraded the stock from Market Perform to Outperform, with a price target of $230.00.<\/p>\n<p><strong>Biohaven (BHVN)<\/strong> \u2014 JPMorgan raised its price target from $14.00 to $35.00, maintaining an Overweight rating.<\/p>\n<p><strong>Biogen (BIIB)<\/strong> \u2014 H.C. Wainwright set a price target of $270.00, with a Buy rating.<\/p>\n<p><strong>BILL (BILL)<\/strong> \u2014 TD Cowen raised its price target from $66.00 to $76.00, maintaining a Buy rating.<\/p>\n<p><strong>BILL (BILL)<\/strong> \u2014 Susquehanna downgraded the stock from Positive to Neutral, with a price target of $73.00.<\/p>\n<p><strong>Bullish (BLSH)<\/strong> \u2014 JPMorgan lowered its price target from $28.00 to $26.00, maintaining a Neutral rating.<\/p>\n<p><strong>Bullish (BLSH)<\/strong> \u2014 Rosenblatt Securities lowered its price target from $30.00 to $22.00, maintaining a Neutral rating.<\/p>\n<p><strong>Bullish (BLSH)<\/strong> \u2014 Canaccord Genuity lowered its price target from $45.00 to $40.00, maintaining a Buy rating.<\/p>\n<p><strong>BioNTech (BNTX)<\/strong> \u2014 JPMorgan raised its price target from $92.00 to $93.00, maintaining a Neutral rating.<\/p>\n<p><strong>BOX (BOX)<\/strong> \u2014 UBS upgraded the stock from Neutral to Buy and adjusted its price target from $37.00 to $55.00.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 DA Davidson raised its price target from $15.00 to $17.00, maintaining a Buy rating.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 Stifel raised its price target from $15.00 to $18.00, maintaining a Buy rating.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 TD Cowen raised its price target from $9.00 to $15.00, maintaining a Hold rating.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 UBS raised its price target from $9.50 to $15.00, maintaining a Neutral rating.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 JPMorgan raised its price target from $15.00 to $18.00, maintaining an Overweight rating.<\/p>\n<p><strong>BellRing Brands (BRBR)<\/strong> \u2014 Bernstein raised its price target from $13.00 to $15.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Brown &amp; Brown (BRO)<\/strong> \u2014 Wells Fargo upgraded the stock from Equal Weight to Overweight and adjusted its price target from $68.00 to $82.00.<\/p>\n<p><strong>BRT Apartments (BRT)<\/strong> \u2014 Citizens Jmp lowered its price target from $20.00 to $17.00, maintaining a Market Outperform rating.<\/p>\n<p><strong>CAE (CAE)<\/strong> \u2014 Morgan Stanley upgraded the stock from Underweight to Equal Weight.<\/p>\n<p><strong>Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 Barclays raised its price target from $124.00 to $130.00, maintaining an Overweight rating.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 Guggenheim raised its price target from $89.00 to $120.00, maintaining a Buy rating.<\/p>\n<p><strong>Cognition Therapeutics (CGTX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $3.00.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Oppenheimer raised its price target from $120.00 to $124.00, maintaining an Outperform rating.<\/p>\n<p><strong>Cigna Group (CI)<\/strong> \u2014 RBC Capital Markets raised its price target from $337.00 to $346.00, maintaining an Outperform rating.<\/p>\n<p><strong>Cummins (CMI)<\/strong> \u2014 Argus lowered its price target from $770.00 to $609.00, maintaining a Buy rating.<\/p>\n<p><strong>Cheniere Energy Partners (CQP)<\/strong> \u2014 RBC Capital Markets raised its price target from $65.00 to $68.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 JPMorgan lowered its price target from $115.00 to $110.00, maintaining an Overweight rating.<\/p>\n<p><strong>CoinShares (CSHR)<\/strong> \u2014 Keefe Bruyette &amp; Woods updated its price target.<\/p>\n<p><strong>Cognizant Technology Solutions (CTSH)<\/strong> \u2014 Bank of America resumed coverage with a Neutral rating and a price target of $70.00.<\/p>\n<p><strong>Corteva (CTVA)<\/strong> \u2014 Barclays resumed coverage with an Equal Weight rating and a price target of $11.00.<\/p>\n<p><strong>Walt Disney (DIS)<\/strong> \u2014 Morgan Stanley raised its price target from $133.00 to $138.00, maintaining an Overweight rating.<\/p>\n<p><strong>Dolby Laboratories (DLB)<\/strong> \u2014 Baird lowered its price target from $62.00 to $60.00, maintaining a Neutral rating.<\/p>\n<p><strong>Docusign (DOCU)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and adjusted its price target from $70.00 to $85.00.<\/p>\n<p><strong>Duke Energy (DUK)<\/strong> \u2014 BMO Capital Markets raised its price target from $128.00 to $138.00, maintaining an Outperform rating.<\/p>\n<p><strong>Duke Energy (DUK)<\/strong> \u2014 Piper Sandler set a price target of $138.00.<\/p>\n<p><strong>Duke Energy (DUK)<\/strong> \u2014 TD Cowen set a price target of $138.00.<\/p>\n<p><strong>Ecolab (ECL)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating.<\/p>\n<p><strong>Ecolab (ECL)<\/strong> \u2014 Mizuho raised its price target from $327.00 to $350.00, maintaining an Outperform rating.<\/p>\n<p><strong>Ecolab (ECL)<\/strong> \u2014 Barclays raised its price target from $300.00 to $385.00, maintaining an Overweight rating.<\/p>\n<p><strong>Equifax (EFX)<\/strong> \u2014 Barclays raised its price target from $155.00 to $185.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Edison International (EIX)<\/strong> \u2014 JPMorgan updated its price target.<\/p>\n<p><strong>Elanco Animal Health (ELAN)<\/strong> \u2014 Barclays raised its price target from $30.00 to $32.00, maintaining an Overweight rating.<\/p>\n<p><strong>EquipmentShare.com (EQPT)<\/strong> \u2014 UBS lowered its price target from $22.00 to $17.00, maintaining a Neutral rating.<\/p>\n<p><strong>Eagle Materials (EXP)<\/strong> \u2014 JPMorgan lowered its price target from $200.00 to $190.00, maintaining a Neutral rating.<\/p>\n<p><strong>Expeditors International of Washington (EXPD)<\/strong> \u2014 Citizens Jmp upgraded the stock from Market Perform to Outperform, with a price target of $240.00.<\/p>\n<p><strong>Expeditors International of Washington (EXPD)<\/strong> \u2014 Morgan Stanley raised its price target from $100.00 to $115.00, maintaining an Underweight rating.<\/p>\n<p><strong>Expeditors International of Washington (EXPD)<\/strong> \u2014 Bank of America raised its price target from $230.00 to $234.00, maintaining a Buy rating.<\/p>\n<p><strong>Expeditors International of Washington (EXPD)<\/strong> \u2014 UBS raised its price target from $245.00 to $252.00, maintaining a Buy rating.<\/p>\n<p><strong>Ford Motor (F)<\/strong> \u2014 DZ Bank upgraded the stock from Hold to Buy, with a price target of $15.00.<\/p>\n<p><strong>Figure Technology Solutions (FIGR)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a price target of $50.00.<\/p>\n<p><strong>Fomento Economico Mexicano (FMX)<\/strong> \u2014 Barclays upgraded the stock from Equal Weight to Overweight, with a price target of $155.00.<\/p>\n<p><strong>Finance of America Companies (FOA)<\/strong> \u2014 B. Riley Financial lowered its price target from $32.00 to $25.00, maintaining a Buy rating.<\/p>\n<p><strong>JFrog (FROG)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n<p><strong>Golub Capital BDC (GBDC)<\/strong> \u2014 Wells Fargo lowered its price target from $13.00 to $12.00, maintaining an Overweight rating.<\/p>\n<p><strong>Gladstone Capital (GLAD)<\/strong> \u2014 Raymond James maintained its Market Perform rating.<\/p>\n<p><strong>Global-e Online (GLBE)<\/strong> \u2014 Piper Sandler maintained its Overweight rating with a price target of $52.00.<\/p>\n<p><strong>Global-e Online (GLBE)<\/strong> \u2014 UBS lowered its price target from $54.00 to $50.00, maintaining a Buy rating.<\/p>\n<p><strong>Global-e Online (GLBE)<\/strong> \u2014 Bank of America lowered its price target from $52.00 to $50.00, maintaining a Buy rating.<\/p>\n<p><strong>Global-e Online (GLBE)<\/strong> \u2014 Morgan Stanley lowered its price target from $50.00 to $49.00, maintaining an Overweight rating.<\/p>\n<p><strong>Global-e Online (GLBE)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n<p><strong>Generac (GNRC)<\/strong> \u2014 TD Cowen raised its price target from $285.00 to $295.00, maintaining a Buy rating.<\/p>\n<p><strong>Global Payments (GPN)<\/strong> \u2014 Truist set a price target of $86.00.<\/p>\n<p><strong>Gulfport Energy (GPOR)<\/strong> \u2014 UBS lowered its price target from $217.00 to $210.00, maintaining a Buy rating.<\/p>\n<p><strong>Green Plains (GPRE)<\/strong> \u2014 Oppenheimer maintained its Outperform rating.<\/p>\n<p><strong>HawkEye 360 (HAWK)<\/strong> \u2014 William Blair maintained its Outperform rating.<\/p>\n<p><strong>HawkEye 360 (HAWK)<\/strong> \u2014 Oppenheimer initiated coverage with an Outperform rating and a price target of $30.00.<\/p>\n<p><strong>Harley-Davidson (HOG)<\/strong> \u2014 StoneX initiated coverage with a Buy rating and a price target of $40.00.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Morgan Stanley raised its price target from $370.00 to $475.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>International Paper (IP)<\/strong> \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n<p><strong>Innate Pharma (IPHA)<\/strong> \u2014 Leerink Partners downgraded the stock from Outperform to Market Perform, with a price target of $1.00.<\/p>\n<p><strong>Quince Therapeutics (IRLA)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a price target of $70.00.<\/p>\n<p><strong>Disc Medicine (IRON)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a price target of $170.00.<\/p>\n<p><strong>ITG (ITG)<\/strong> \u2014 UBS lowered its price target from $18.00 to $10.00, maintaining a Buy rating.<\/p>\n<p><strong>JBS (JBS)<\/strong> \u2014 UBS lowered its price target from $17.00 to $16.50, maintaining a Buy rating.<\/p>\n<p><strong>JD.com (JD)<\/strong> \u2014 Susquehanna lowered its price target from $30.00 to $28.00, maintaining a Neutral rating.<\/p>\n<p><strong>J &amp; J Snack Foods (JJSF)<\/strong> \u2014 StoneX raised its price target from $120.00 to $125.00, maintaining a Buy rating.<\/p>\n<p><strong>Jumia Technologies (JMIA)<\/strong> \u2014 StoneX set a price target of $13.00, maintaining a Buy rating.<\/p>\n<p><strong>Jumia Technologies (JMIA)<\/strong> \u2014 Cantor Fitzgerald lowered its price target from $9.00 to $5.00, maintaining an Overweight rating.<\/p>\n<p><strong>Kodiak AI (KDK)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a price target of $4.00.<\/p>\n<p><strong>OrthoPediatrics (KIDS)<\/strong> \u2014 Piper Sandler updated its price target from $30.00 to $45.00, maintaining an Overweight rating.<\/p>\n<p><strong>Kingstone Companies (KINS)<\/strong> \u2014 Piper Sandler initiated coverage with an Overweight rating and a price target of $24.00.<\/p>\n<p><strong>Kodiak Sciences (KOD)<\/strong> \u2014 JPMorgan raised its price target from $124.00 to $128.00, maintaining an Overweight rating.<\/p>\n<p><strong>Kornit Digital (KRNT)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a price target of $23.00.<\/p>\n<p><strong>Laser Photonics (LASE)<\/strong> \u2014 H.C. Wainwright initiated coverage with a Buy rating and a price target of $2.00.<\/p>\n<p><strong>LGN (LGN)<\/strong> \u2014 Tigress Financial lowered its price target from $130.00 to $85.00, maintaining a Buy rating.<\/p>\n<p><strong>Linde (LIN)<\/strong> \u2014 Kepler Capital Markets upgraded the stock from Hold to Buy and adjusted its price target from $490.00 to $601.00.<\/p>\n<p><strong>Cheniere Energy (LNG)<\/strong> \u2014 RBC Capital Markets raised its price target from $319.00 to $373.00, maintaining an Outperform rating.<\/p>\n<p><strong>Athira Pharma (LONA)<\/strong> \u2014 Mizuho lowered its price target from $13.00 to $12.00, maintaining an Outperform rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 RBC Capital Markets lowered its price target from $231.00 to $229.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 Barclays lowered its price target from $260.00 to $255.00, maintaining an Overweight rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 UBS lowered its price target from $275.00 to $269.00, maintaining a Buy rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 DA Davidson maintained its Neutral rating with a price target of $245.00.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 Baird lowered its price target from $270.00 to $250.00, maintaining an Outperform rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 Truist lowered its price target from $254.00 to $240.00, maintaining a Buy rating.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 Mizuho lowered its price target from $250.00 to $248.00, maintaining an Outperform rating.<\/p>\n<p><strong>Microbot Medical (MBOT)<\/strong> \u2014 B. Riley Financial lowered its price target from $4.00 to $3.00, maintaining a Buy rating.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 BTIG Research maintained its Buy rating.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 Bank of America lowered its price target from $540.00 to $450.00, maintaining a Buy rating.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 UBS resumed coverage with a Buy rating and a price target of $450.00.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 Needham &amp; Company LLC initiated coverage with a Buy rating.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 Susquehanna downgraded the stock to Hold.<\/p>\n<p><strong>MongoDB (MDB)<\/strong> \u2014 Citigroup upgraded the stock from Market Outperform to Outperform.<\/p>\n<p><strong>Medtronic (MDT)<\/strong> \u2014 BTIG Research raised its price target from $99.00 to $109.00, maintaining a Buy rating.<\/p>\n<p><strong>MercadoLibre (MELI)<\/strong> \u2014 Bank of America lowered its price target from $2,400.00 to $2,000.00, maintaining a Buy rating.<\/p>\n<p><strong>McGraw Hill (MH)<\/strong> \u2014 Morgan Stanley raised its price target from $14.00 to $15.00, maintaining an Overweight rating.<\/p>\n<p><strong>McGraw Hill (MH)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a price target of $19.00.<\/p>\n<p><strong>McGraw Hill (MH)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $17.00.<\/p>\n<p><strong>MINISO Group (MNSO)<\/strong> \u2014 JPMorgan lowered its price target from $16.00 to $14.00, maintaining an Overweight rating.<\/p>\n<p><strong>Modine Manufacturing (MOD)<\/strong> \u2014 DA Davidson maintained its Buy rating with a price target of $235.00.<\/p>\n<p><strong>Modine Manufacturing (MOD)<\/strong> \u2014 Cantor Fitzgerald raised its price target from $178.00 to $200.00, maintaining an Overweight rating.<\/p>\n<p><strong>Modine Manufacturing (MOD)<\/strong> \u2014 Oppenheimer raised its price target from $215.00 to $240.00, maintaining an Outperform rating.<\/p>\n<p><strong>Modine Manufacturing (MOD)<\/strong> \u2014 KeyCorp maintained its Overweight rating.<\/p>\n<p><strong>Marsh &amp; McLennan Companies (MRSH)<\/strong> \u2014 Wells Fargo upgraded the stock from Equal Weight to Overweight and adjusted its price target from $197.00 to $235.00.<\/p>\n<p><strong>Microsoft (MSFT)<\/strong> \u2014 H.C. Wainwright upgraded the stock from Neutral to Buy.<\/p>\n<p><strong>MSG Rangers (MSGR)<\/strong> \u2014 BTIG Research raised its price target from $257.00 to $313.00, maintaining a Buy rating.<\/p>\n<p><strong>MSG Rangers (MSGR)<\/strong> \u2014 Guggenheim raised its price target from $278.00 to $299.00, maintaining a Buy rating.<\/p>\n<p><strong>SOLV Energy (MWH)<\/strong> \u2014 Guggenheim lowered its price target from $50.00 to $42.00, maintaining a Buy rating.<\/p>\n<p><strong>NiSource (NI)<\/strong> \u2014 Bank of America raised its price target from $45.00 to $48.00, maintaining a Buy rating.<\/p>\n<p><strong>NiSource (NI)<\/strong> \u2014 JPMorgan resumed coverage with an Overweight rating and a price target of $53.00.<\/p>\n<p><strong>Terra Innovatum Global S.R.L. (NKLR)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n<p><strong>NXP Semiconductors (NXPI)<\/strong> \u2014 StoneX initiated coverage with a Buy rating and a price target of $340.00.<\/p>\n<p><strong>Norcros (NXR)<\/strong> \u2014 Shore Capital Group maintained its House Stock rating.<\/p>\n<p><strong>Oaktree Specialty Lending (OCSL)<\/strong> \u2014 Wells Fargo maintained its Positive rating.<\/p>\n<p><strong>Oaktree Specialty Lending (OCSL)<\/strong> \u2014 Wells Fargo lowered its price target from $12.00 to $11.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>BeOne Medicines (ONC)<\/strong> \u2014 JPMorgan raised its price target from $445.00 to $460.00, maintaining an Overweight rating.<\/p>\n<p><strong>Oncolytics Biotech (ONCY)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n<p><strong>Oric Pharmaceuticals (ORIC)<\/strong> \u2014 H.C. Wainwright lowered its price target from $27.00 to $20.00, maintaining a Buy rating.<\/p>\n<p><strong>Oruka Therapeutics (ORKA)<\/strong> \u2014 Jefferies Financial Group set a price target of $133.00, with a Buy rating.<\/p>\n<p><strong>Oncobiologics (OTLK)<\/strong> \u2014 Piper Sandler initiated coverage with an Overweight rating.<\/p>\n<p><strong>Owlet (OWLT)<\/strong> \u2014 William Blair maintained its Outperform rating.<\/p>\n<p><strong>Owlet (OWLT)<\/strong> \u2014 UBS maintained its Outperform rating.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Needham &amp; Company LLC lowered its price target from $185.00 to $150.00, maintaining a Buy rating.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Guggenheim maintained its Buy rating with a price target of $215.00.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 UBS raised its price target from $88.00 to $89.00, maintaining a Sell rating.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Piper Sandler updated its price target from $162.00 to $166.00, maintaining an Overweight rating.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Barclays lowered its price target from $132.00 to $115.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 TD Cowen maintained its Buy rating with a price target of $170.00.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Wedbush set a price target of $155.00.<\/p>\n<p><strong>Everpure (P)<\/strong> \u2014 Evercore maintained its Outperform rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating with a price target of $475.00.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Citigroup raised its price target from $440.00 to $445.00, maintaining a Buy rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Wells Fargo lowered its price target from $525.00 to $510.00, maintaining an Overweight rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Barclays raised its price target from $375.00 to $385.00, maintaining an Overweight rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Piper Sandler updated its price target from $410.00 to $450.00, maintaining an Overweight rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Bank of America raised its price target from $420.00 to $430.00, maintaining a Buy rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Northland Securities raised its price target from $360.00 to $379.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 UBS raised its price target from $390.00 to $400.00, maintaining a Neutral rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 JPMorgan raised its price target from $384.00 to $415.00, maintaining an Overweight rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Baird raised its price target from $420.00 to $465.00, maintaining an Outperform rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Rosenblatt Securities raised its price target from $415.00 to $460.00, maintaining a Buy rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Bernstein raised its price target from $351.00 to $368.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Needham &amp; Company LLC maintained its Buy rating with a price target of $425.00.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 BTIG Research raised its price target from $425.00 to $442.00, maintaining a Buy rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Mizuho raised its price target from $415.00 to $440.00, maintaining an Outperform rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 Susquehanna raised its price target from $415.00 to $425.00, maintaining a Positive rating.<\/p>\n<p><strong>Palo Alto Networks (PANW)<\/strong> \u2014 DA Davidson raised its price target from $420.00 to $430.00, maintaining a Buy rating.<\/p>\n<p><strong>Paychex (PAYX)<\/strong> \u2014 Bank of America resumed coverage with a Neutral rating and a price target of $120.00.<\/p>\n<p><strong>Pacific Gas &amp; Electric (PCG)<\/strong> \u2014 JPMorgan raised its price target from $17.00 to $19.00, maintaining an Overweight rating.<\/p>\n<p><strong>PDD (PDD)<\/strong> \u2014 Jefferies Financial Group set a price target of $120.00, with a Buy rating.<\/p>\n<p><strong>Progressive (PGR)<\/strong> \u2014 Citigroup lowered its price target from $261.00 to $260.00, maintaining a Buy rating.<\/p>\n<p><strong>Progressive (PGR)<\/strong> \u2014 Wells Fargo lowered its price target from $196.00 to $194.00, maintaining an Underweight rating.<\/p>\n<p><strong>Progressive (PGR)<\/strong> \u2014 Bank of America lowered its price target from $262.00 to $261.00, maintaining a Buy rating.<\/p>\n<p><strong>Parker-Hannifin (PH)<\/strong> \u2014 Susquehanna maintained its Positive rating.<\/p>\n<p><strong>Phreesia (PHR)<\/strong> \u2014 DA Davidson raised its price target from $13.00 to $15.00, maintaining a Buy rating.<\/p>\n<p><strong>PICS (PICS)<\/strong> \u2014 Mizuho lowered its price target from $16.00 to $8.00, maintaining an Outperform rating.<\/p>\n<p><strong>Pantheon Infrastructure (PINT)<\/strong> \u2014 Canaccord Genuity downgraded the stock to Hold.<\/p>\n<p><strong>Planet Labs PBC (PL)<\/strong> \u2014 Oppenheimer initiated coverage with an Outperform rating and a price target of $18.00.<\/p>\n<p><strong>Promis Neurosciences (PMN)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $18.00.<\/p>\n<p><strong>Prenetics Global (PRE)<\/strong> \u2014 B. Riley Financial lowered its price target from $37.00 to $31.00, maintaining a Buy rating.<\/p>\n<p><strong>Primoris Services (PRIM)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold and adjusted its price target from $99.00 to $67.00.<\/p>\n<p><strong>Privia Health Group (PRVA)<\/strong> \u2014 RBC Capital Markets raised its price target from $31.00 to $32.00, maintaining an Outperform rating.<\/p>\n<p><strong>PayPal (PYPL)<\/strong> \u2014 Susquehanna maintained its Positive rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 Bank of America raised its price target from $45.00 to $48.00, maintaining a Neutral rating.<\/p>\n<p><strong>Redwire (RDW)<\/strong> \u2014 Oppenheimer initiated coverage with a Market Perform rating.<\/p>\n<p><strong>Reinsurance Group of America (RGA)<\/strong> \u2014 UBS upgraded the stock from Neutral to Buy and adjusted its price target from $236.00 to $325.00.<\/p>\n<p><strong>Cartesian Therapeutics (RNAC)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $25.00.<\/p>\n<p><strong>Construction Partners (ROAD)<\/strong> \u2014 Truist set a price target of $90.00.<\/p>\n<p><strong>Rockwell Automation (ROK)<\/strong> \u2014 Oppenheimer maintained its Market Perform rating.<\/p>\n<p><strong>Rockwell Automation (ROK)<\/strong> \u2014 DA Davidson maintained its Neutral rating with a price target of $450.00.<\/p>\n<p><strong>Rockwell Automation (ROK)<\/strong> \u2014 Mizuho raised its price target from $375.00 to $415.00, maintaining a Neutral rating.<\/p>\n<p><strong>Rockwell Automation (ROK)<\/strong> \u2014 KeyCorp maintained its Overweight rating.<\/p>\n<p><strong>Red Robin Gourmet Burgers (RRGB)<\/strong> \u2014 Craig Hallum raised its price target from $14.50 to $15.50, maintaining a Buy rating.<\/p>\n<p><strong>Research Solutions (RSSS)<\/strong> \u2014 Maxim Group downgraded the stock from Buy to Hold.<\/p>\n<p><strong>Scribe Therapeutics (SCTX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $60.00.<\/p>\n<p><strong>Septerna (SEPN)<\/strong> \u2014 JPMorgan raised its price target from $48.00 to $51.00, maintaining an Overweight rating.<\/p>\n<p><strong>Super Group (SGHC) (SGHC)<\/strong> \u2014 Rothschild &amp; Co Redburn initiated coverage with a Buy rating and a price target of $15.00.<\/p>\n<p><strong>Signet Jewelers (SIG)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 Susquehanna lowered its price target from $200.00 to $170.00, maintaining a Positive rating.<\/p>\n<p><strong>Synopsys (SNPS)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a price target of $640.00.<\/p>\n<p><strong>Southern (SO)<\/strong> \u2014 Jefferies Financial Group maintained its Hold rating.<\/p>\n<p><strong>Spire (SR)<\/strong> \u2014 Wells Fargo raised its price target from $93.00 to $94.00, maintaining an Overweight rating.<\/p>\n<p><strong>Spire (SR)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold, with a price target of $94.00.<\/p>\n<p><strong>Sarepta Therapeutics (SRPT)<\/strong> \u2014 JPMorgan raised its price target from $20.00 to $22.00, maintaining a Neutral rating.<\/p>\n<p><strong>SoundThinking (SSTI)<\/strong> \u2014 Cantor Fitzgerald withdrew its coverage.<\/p>\n<p><strong>Swarmer (SWMR)<\/strong> \u2014 Oppenheimer initiated coverage with an Outperform rating and a price target of $20.00.<\/p>\n<p><strong>BBB Foods (TBBB)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a price target of $90.00.<\/p>\n<p><strong>Teladoc Health (TDOC)<\/strong> \u2014 Truist raised its price target from $8.00 to $9.00, maintaining a Hold rating.<\/p>\n<p><strong>Atlassian (TEAM)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and adjusted its price target from $160.00 to $150.00.<\/p>\n<p><strong>Tempus AI (TEM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a price target of $85.00.<\/p>\n<p><strong>Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 Barclays raised its price target from $47.00 to $50.00, maintaining an Overweight rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Baird raised its price target from $175.00 to $180.00, maintaining a Neutral rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Bernstein raised its price target from $154.00 to $160.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 BTIG Research maintained its Neutral rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 KGI Securities upgraded the stock from Neutral to Outperform, with a price target of $195.00.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Truist raised its price target from $167.00 to $172.00, maintaining a Hold rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Guggenheim raised its price target from $175.00 to $180.00, maintaining a Buy rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 BMO Capital Markets raised its price target from $160.00 to $170.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Bank of America raised its price target from $141.00 to $145.00, maintaining an Underperform rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 BNP Paribas Exane updated its price target from $128.00 to $130.00, maintaining an Underperform rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Morgan Stanley raised its price target from $170.00 to $185.00, maintaining an Overweight rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 DA Davidson raised its price target from $185.00 to $198.00, maintaining a Buy rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 TD Cowen raised its price target from $160.00 to $175.00, maintaining a Hold rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Piper Sandler raised its price target from $153.00 to $176.00, maintaining a Neutral rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 RBC Capital Markets raised its price target from $178.00 to $183.00, maintaining an Outperform rating.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 Mizuho raised its price target from $150.00 to $168.00, maintaining a Neutral rating.<\/p>\n<p><strong>TJX Companies (TJX)<\/strong> \u2014 Wells Fargo set a price target of $135.00, with a Cautious rating.<\/p>\n<p><strong>TJX Companies (TJX)<\/strong> \u2014 Barclays lowered its price target from $188.00 to $186.00, maintaining an Overweight rating.<\/p>\n<p><strong>TJX Companies (TJX)<\/strong> \u2014 BTIG Research maintained its Buy rating with a price target of $190.00.<\/p>\n<p><strong>TJX Companies (TJX)<\/strong> \u2014 Guggenheim maintained its Buy rating with a price target of $152.00.<\/p>\n<p><strong>Tencent Music Entertainment Group (TME)<\/strong> \u2014 Barclays lowered its price target from $20.00 to $19.00, maintaining an Overweight rating.<\/p>\n<p><strong>TransUnion (TRU)<\/strong> \u2014 Barclays raised its price target from $70.00 to $82.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>TELUS (TU)<\/strong> \u2014 National Bank Financial upgraded the stock from Sector Perform to Outperform.<\/p>\n<p><strong>Texas Roadhouse (TXRH)<\/strong> \u2014 JPMorgan lowered its price target from $200.00 to $195.00, maintaining a Neutral rating.<\/p>\n<p><strong>Uber Technologies (UBER)<\/strong> \u2014 Citizens Jmp set a price target of $100.00.<\/p>\n<p><strong>Uber Technologies (UBER)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n<p><strong>Unusual Machines (UMAC)<\/strong> \u2014 Oppenheimer initiated coverage with an Outperform rating and a price target of $30.00.<\/p>\n<p><strong>Unum Group (UNM)<\/strong> \u2014 UBS upgraded the stock from Neutral to Buy and adjusted its price target from $94.00 to $111.00.<\/p>\n<p><strong>Upbound Group (UPBD)<\/strong> \u2014 Loop Capital downgraded the stock from Buy to Hold, with a price target of $26.00.<\/p>\n<p><strong>Upstart (UPST)<\/strong> \u2014 Truist set a price target of $30.00.<\/p>\n<p><strong>Universal Technical Institute (UTI)<\/strong> \u2014 Rosenblatt Securities set a price target of $35.00.<\/p>\n<p><strong>Universal Technical Institute (UTI)<\/strong> \u2014 Lake Street Capital lowered its price target from $37.00 to $29.00, maintaining a Buy rating.<\/p>\n<p><strong>Universal Technical Institute (UTI)<\/strong> \u2014 B. Riley Financial lowered its price target from $45.00 to $39.00, maintaining a Buy rating.<\/p>\n<p><strong>Veeva Systems (VEEV)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and adjusted its price target from $325.00 to $310.00.<\/p>\n<p><strong>Viking (VIK)<\/strong> \u2014 Citigroup lowered its price target from $113.00 to $111.00, maintaining a Buy rating.<\/p>\n<p><strong>Viking (VIK)<\/strong> \u2014 StoneX raised its price target from $99.00 to $106.00, maintaining a Buy rating.<\/p>\n<p><strong>Viking (VIK)<\/strong> \u2014 Bernstein maintained its Outperform rating.<\/p>\n<p><strong>Viridian Therapeutics (VRDN)<\/strong> \u2014 Bank of America initiated coverage with a Buy rating and a price target of $47.00.<\/p>\n<p><strong>Valvoline (VVV)<\/strong> \u2014 TD Cowen set a price target of $40.00, with a Buy rating.<\/p>\n<p><strong>Valvoline (VVV)<\/strong> \u2014 Jefferies Financial Group set a price target of $45.00, with a Buy rating.<\/p>\n<p><strong>Vylor (VYLR)<\/strong> \u2014 Barclays initiated coverage with an Overweight rating and a price target of $83.00.<\/p>\n<p><strong>Workday (WDAY)<\/strong> \u2014 Barclays lowered its price target from $224.00 to $223.00, maintaining an Overweight rating.<\/p>\n<p><strong>Walmart (WMT)<\/strong> \u2014 TD Cowen set a price target of $125.00, with a Buy rating.<\/p>\n<p><strong>Willis Towers Watson Public (WTW)<\/strong> \u2014 Wells Fargo raised its price target from $360.00 to $390.00, maintaining an Overweight rating.<\/p>\n<p><strong>Woodward (WWD)<\/strong> \u2014 UBS raised its price target from $455.00 to $467.00, maintaining a Buy rating.<\/p>\n<p><strong>Woodward (WWD)<\/strong> \u2014 Jefferies Financial Group set a price target of $425.00, with a Buy rating.<\/p>\n<p><strong>Xencor (XNCR)<\/strong> \u2014 JPMorgan raised its price target from $21.00 to $37.00, maintaining a Neutral rating.<\/p>\n<p><strong>XP (XP)<\/strong> \u2014 JPMorgan lowered its price target from $38.00 to $18.00, maintaining an Overweight rating.<\/p>\n<p><strong>Zai Lab (ZLAB)<\/strong> \u2014 JPMorgan raised its price target from $36.00 to $37.00, maintaining an Overweight rating.<\/p>\n<p><strong>Zoom Communications (ZM)<\/strong> \u2014 StoneX raised its price target from $125.00 to $130.00, maintaining a Buy rating.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) The Amercan market outlook remains mixed, with analysts showing optimism toward technology, healthcare and industrial stocks, while consumer discretionary and financial&hellip;<\/p>\n","protected":false},"author":3,"featured_media":77265,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Analyst Ratings Updates: November 19, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Ratings Updates: November 19, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) The Amercan market outlook remains mixed, with analysts showing optimism toward technology, healthcare and industrial stocks, while consumer discretionary and financial&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-20T03:37:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-20T03:44:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/US-ratings.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"20 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Ratings Updates: November 19, 2026\",\"datePublished\":\"2026-11-20T03:37:23+00:00\",\"dateModified\":\"2026-11-20T03:44:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\"},\"wordCount\":3993,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\",\"name\":\"American Analyst Ratings Updates: November 19, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-20T03:37:23+00:00\",\"dateModified\":\"2026-11-20T03:44:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Ratings Updates: November 19, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Ratings Updates: November 19, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Ratings Updates: November 19, 2026","og_description":"Analyst Ratings (USA) The Amercan market outlook remains mixed, with analysts showing optimism toward technology, healthcare and industrial stocks, while consumer discretionary and financial&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-20T03:37:23+00:00","article_modified_time":"2026-11-20T03:44:54+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/US-ratings.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"20 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Ratings Updates: November 19, 2026","datePublished":"2026-11-20T03:37:23+00:00","dateModified":"2026-11-20T03:44:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/"},"wordCount":3993,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/","name":"American Analyst Ratings Updates: November 19, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-20T03:37:23+00:00","dateModified":"2026-11-20T03:44:54+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-updates-november-19-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Ratings Updates: November 19, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=77257"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77257\/revisions"}],"predecessor-version":[{"id":77267,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/77257\/revisions\/77267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/77265"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=77257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=77257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=77257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}